imipramine has been researched along with Myotonic Dystrophy in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Myotonic Dystrophy: Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gascon, GG | 1 |
Staton, RD | 1 |
Patterson, BD | 1 |
Konewko, PJ | 1 |
Wilson, H | 1 |
Carlson, KM | 1 |
Brumback, RA | 1 |
1 trial available for imipramine and Myotonic Dystrophy
Article | Year |
---|---|
A pilot controlled study of the use of imipramine to reduce myotonia.
Topics: Adult; Desipramine; Double-Blind Method; Drug Evaluation; Female; Humans; Imipramine; Male; Middle A | 1989 |